CAPZA1 and nonpapillary renal cell carcinoma: Given that metabolic and cytoskeletal dysregulation could be taken as a hallmark of ccRCC, CAPZA1 may influence lipid metabolic dysregulation-driven tumor progression or metastatic potential.